CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...

In the Phase 1/1b trial, ficerafusp alfa in combination with pembrolizumab resulted in deep and durable anti-tumor activity with improved overall survival (OS) compared to historical benchmarks in ...

NIVOPOSTOP trial data demonstrate a reduction in the risk of recurrence or death with adjuvant nivolumab combined with ...

Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...

Adding nivolumab to adjuvant CRT improved DFS in patients with locally advanced head and neck squamous cell carcinoma at high risk of relapse.

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

has proven its effectiveness in advanced lip and oral cavity cancers, especially cutaneous and squamous cell carcinomas. The rationale for the development of such immunotherapeutic approaches is to ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

A research perspective was recently published in Oncoscience, titled "Squamous cell carcinoma of the oral cavity—follow up treatment and distant metastatic behavior." Up to 90% of tumors in the ...

BUFFALO, NY- December 22, 2023 – A research perspective was recently published in Oncoscience (Volume 10) on August 14, 2023, entitled, “Squamous cell carcinoma of the oral cavity – follow ...

That means that SCC can develop in these areas, too. Squamous cell carcinoma in the mouth: Your oral cavity includes the inside of your cheeks, your gums, the hard palate (the bony roof of your ...

Most oral cancers are squamous cell carcinomas (SCCs ... may spread into deeper layers of tissues around the oral cavity. Verrucous carcinoma is a subtype of SCC. It’s a slow growing cancer ...